Assessing the Predictive Value of High Frequency Algorithm of PURE EP for Low Amplitude Signal Detection

Status unconfirmed

Conditions studied: Cardiac Arrhythmias

In brief

Prior multicenter study demonstrated superiority of PURE EP to conventional mapping. This superiority was seen when comparing small, fractionated signals of interest, near-field vs far-field distinction, and general signal quality (2). Hence, investigators propose a retrospective study to assess the predictive value of high frequency algorithm (HFA) for identifying local physiologic signal under 0.3 mV distinctive of noise.

Key facts

Study ID

NCT05450302

Run by

Kansas City Heart Rhythm Research Foundation

People needed

150

Starts

2023-04-01

Expected to finish

2023-12-01

Last updated by the study team

2023-03-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients (male + Female) with age > 18 years from January 2022 till June 2022 will be included in the study.

You may not qualify if…

• All patients in which PURE EP was not used from January 2022 till June 2022.

Where it is running

• Kansas City Heart Rhythm Institute — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.